Asymmetric homologation of ketones. A new entry to orthogonally protected (2R,4R)-piperidine-2,4-dicarboxylic acid

Journal of Organic Chemistry

Volumn 73, Issue 21, 2008, Pages 8594-8597

  Etayo, Pablo ^a   Badorrey, Ramón ^a   Díaz de Villegas, María D ^a   Gálvez, José A ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL REACTIONS; KETONES;

CHEMICAL EQUATIONS; DICARBOXYLIC ACIDS; GLUTAMIC ACIDS; OXIDATION PROCESSES; PIPERIDINE RINGS;

ORGANIC COMPOUNDS;

2,4 PIPERIDINEDICARBOXYLIC ACID; KETONE DERIVATIVE; PIPERIDONE DERIVATIVE;

ARTICLE; CHEMICAL REACTION; OXIDATION; REACTION ANALYSIS; SYNTHESIS;

GLUTAMIC ACID; KETONES; MOLECULAR CONFORMATION; PIPECOLIC ACIDS; PIPERIDONES;

EID: 55249100747     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo801515k     Document Type: Article

References (55)

1. For reviews on this topic, see: (a) Giannis, A.; Kolter, T. Angew. Chem., Int. Ed. Engl. 1993, 32, 1244-1267.
2. (b) Gante, J. Angew. Chem., Int. Ed. Engl. 1994, 33, 1699-1720.
3. (c) Hanessian, S.; McNaughton-Smith, G.; Lombart, H. G.; Lubell, W. D. Tetrahedron 1997, 53, 12789-12854.
4. (d) Gillespie, P.; Cicariello, J.; Olson, G. L. Biopolymers (Peptide Sci.) 1997, 43, 191-217.
5. (e) Gibson, S. E.; Guillo, N.; Tozer, M. J. Tetrahedron 1999, 55, 585-615.
6. (f) Methods in Organic Chemistry: Synthesis of Peptides and Peptidomimetics; Goodman, M., Felix, A., Moroder, L., Toniolo, C., Eds.; Houben-Weyl; Thieme: Stuttgart, 2003; Vol. E22c.
7. (g) Cowell, S. M.; Lee, Y. S.; Cain, J. P.; Hruby, V. J. Curr. Med. Chem. 2004, 11, 2785-2798.
8. (h) Belvisi, L.; Colombo, L.; Manzoni, L.; Potenza, D.; Scolastico, C. Synlett 2004, 1449-1471.
9. (i) Cluzeau, J.; Lubell, W. D. Biopolymers 2005, 80, 98-150.
10. (j) Handbook of Biologically Active Peptides; Kastin, A. J., Ed.; Elsevier: London, 2006.
11. (k) Tanaka, M. Chem. Pharm. Bull. 2007, 55, 349-358.
12. See, for example: (a) Glenn, M. P.; Fairlie, D. P. Mini-Rev. Med. Chem. 2002, 2, 433-445.
13. (b) Rajesh, S.; Ami, E.; Kotake, T.; Kimura, T.; Hayashi, Y.; Kiso, Y. Bioorg. Med. Chem. Lett. 2002, 12, 3615-3617.
14. (c) Swamy, K. M. K.; Lin, M. J.; Sun, C. M. Mini-Rev. Med. Chem. 2003, 3, 621-631.
15. (d) Kee, S.; Jois, S. D. S. Curr. Pharm. Des. 2003, 9, 1209-1224.
16. (e) Andronati, S. A.; Karaseva, T. L.; Krysko, A. A. Curr. Med. Chem. 2004, 11, 1183-1211.
17. (f) Reissmann, S.; Imhof, D. Curr. Med. Chem. 2004, 11, 2823-2844.
18. Parsons, C. G.; Danysz, W.; Quack, G. Drugs News Perspect. 1998, 11, 523-569.
19. See, for example: (a) Pellicciari, R.; Marinozzi, M.; Camaioni, E.; Nunez, M. D.; Costantino, G.; Gasparini, F.; Giorgi, G.; Macchiarulo, A.; Subramanian, N. J. Org. Chem. 2002, 67, 5497-5507.
20. (b) Conti, P.; De Amici, M.; Grazioso, G.; Roda, G.; Stensbol, T. B.; Bräuner-Osborne, H.; Madsen, U.; Toma, L.; De Micheli, C. Eur. J. Org. Chem. 2003, 4455-4461.
21. (c) Bunch, L.; Liljefors, T.; Greenwood, J. R.; Frydenvang, K.; Bräuner-Osborne, H.; Krogsgaard-Larsen, P.; Madsen, U. J. Org. Chem. 2003, 68, 1489-1495.
22. (d) Ohfune, Y.; Demura, T.; Iwama, S.; Matsuda, H.; Namba, K.; Shimamoto, K.; Shinado, T. Tetrahedron Lett. 2003, 44, 5431-5434.
23. (e) Roda, G.; Conti, P.; De Amici, M.; He, J. T.; Polavarapu, P. L.; De Micheli, C. Tetrahedron: Asymmetry 2004, 15, 3079-3090.
24. (f) Bräuner-Osborne, H.; Bunch, L.; Chopin, N.; Couty, F.; Evano, G.; Jensen, A. A.; Kusk, M.; Nielsen, B.; Rabasso, N. Org. Biomol. Chem. 2005, 3, 3926-3936.
25. (g) Oba, M.; Nishiyama, N.; Nishiyama, K. Tetrahedron 2005, 61, 8456-8464.
26. (h) Conti, P.; Pinto, A.; Tamborini, L.; Gracioso, G.; De Sarro, G.; Bräuner-Osborne, H.; Szabo, G.; Harsing, L. G.; De Micheli, C. ChemMedChem 2007, 2, 1639-1647.
27. (i) Conti, P.; Caligiuri, A.; Pinto, A.; Roda, G.; Tamborini, L.; Nielsen, B.; Madsen, U.; Frydenvan, K.; Colombo, A.; De Micheli, C. Eur. J. Med. Chem. 2007, 42, 1056-1068.
28. (j) Maison, W. Eur. J. Org. Chem. 2007, 2276-2284.
29. (a) Bräuner-Osborne, H.; Egebjerg, J.; Nielsen, E.; Madsen, U.; Krogsgaard-Larsen, P. J. Med. Chem. 2000, 43, 2609-2645.
30. (b) Kew, J. N. C.; Kemp, J. A. Psychopharmacology 2005, 179, 4-29.
31. (c) Swanson, C. J.; Bures, M.; Johnson, M. P.; Linden, A. M.; Monn, J. A.; Schoepp, D. D. Nat. Rev. Drug Discovery 2005, 4, 131-144.
32. (a) Madsen, U.; Brehm, L.; Schaumburg, K.; Jorgensen, F. S.; Krogsgaard-Larsen, P. J. Med. Chem. 1990, 33, 374-380.
33. (b) MacCoss, M.; Mills, S. G. PCT Int. Appl. WO 9522525 A1, 19950824.
34. (c) Hamanaka, E. S.; Hayward, C. M. PCT Int. Appl. WO 9748701 A1, 19971224.
35. (d) McClure, K. F. PCT Int. Appl. WO 9834918 A1, 19980813.
36. (e) Bocan, T. M. A. PCT Int. Appl. WO 2000004892 A2, 20000203.
37. (f) Letavic, M. A.; Axt, M. Z.; Barberia, J. T.; Carty, T. J.; Danley, D. E.; Geoghegan, K. F.; Halim, N. S.; Hoth, L. R.; Kamath, A. V.; Laird, E. R.; Lopresti-Morrow, L. L.; McClure, K. F.; Mitchell, P. G.; Natarajan, V.; Noe, M. C.; Pandit, L. R.; Schulte, G. K.; Snow, S. L.; Sweeney, F. J.; Tan, D. H.; Yu, C. H. Bioorg. Med. Chem. Lett. 2002, 12, 1387-1390.
38. (a) Mastafanova, L. I.; Turchin, K. F.; Yevstratova, M. I.; Sheinker, Y. N.; Yakhontov, L. N. Khim. Geterotsikl. Soedin. 1985, 367-371.
39. (b) Nazih, A.; Schneider, M. R.; Mann, A. Synlett 1998, 1337-1338.
40. (c) Nielsen, J.; Bols, M.; Carstensen, E. V.; Willert, M. PCT Int. Appl. WO 9903832 A1, 19990128.
41. (a) Hanessian, S.; Margarita, R. Tetrahedron Lett. 1998, 39, 5887-5890.
42. (b) Del Bosco, M.; Johnstone, A. N. C.; Bazza, G.; Lopatriello, S.; North, M. Tetrahedron 1995, 51, 8545-8554.
43. (a) Etayo, P.; Badorrey, R.; Díaz-de-Villegas, M. D.; Gálvez, J. A. Chem. Commun. 2006, 3420-3422.
44. (b) Etayo, P.; Badorrey, R.; Díaz-de-Villegas, M. D.; Gálvez, J. A. Synlett 2006, 2799-2803.
45. (c) Etayo, P.; Badorrey, R.; Díaz-de-Villegas, M. D.; Gálvez, J. A. J. Org. Chem. 2007, 72, 1005-1008.
46. (d) Etayo, P.; Badorrey, R.; Díaz-de-Villegas, M. D.; Gálvez, J. A. Tetrahedron: Asymmetry 2007, 18, 2812-2819.
47. (e) Etayo, P.; Badorrey, R.; Díaz-de-Villegas, M. D.; Gálvez, J. A. Tetrahedron Lett. 2008, 49, 2251-2253.
48. Badorrey, R.; Cativiela, C.; Díaz-de-Villegas, M. D.; Gálvez, J. A. Tetrahedron 1999, 55, 7601-7612.
49. Badham, N. F. Tetrahedron 2004, 60, 11-42.
50. (a) Schöllkopf, U.; Schöder, R.; Stafforst, D. Liebigs Ann. Chem. 1974, 44-53.
51. (b) Schöllkopf, U.; Stafforst, D.; Jentch, R. Liebigs Ann. Chem. 1977, 1167-1173.
52. Moskal, J.; van Leusen, A. M. Recl. Trav. Chim. Pays-Bas 1987, 106, 137-141.
53. Blanchette, M. A.; Choy, W.; Davis, J.; Essenfield, A. P.; Masamune, S.; Roush, W. R.; Sakai, T. Tetrahedron Lett. 1984, 25, 2183-2186.
54. 1H NOESY experiments.
55. 6. In the NOESY spectrum, duplicate signals clearly show exchange cross peaks.